These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31545274)
1. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling. Yu L; Wang C; Pan F; Liu Y; Ren X; Zeng H; Shi Y Biomed Pharmacother; 2019 Oct; 118():109361. PubMed ID: 31545274 [TBL] [Abstract][Full Text] [Related]
2. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling. Liu L; Yu D; Shi H; Li J; Meng L Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885 [TBL] [Abstract][Full Text] [Related]
3. LINC01614 activated by SP1 promoted malignant behavior of triple-negative breast cancer cells via the WNT/b-Catenin signaling pathway. Chen T; Shi K; Sun S Rev Invest Clin; 2024 Oct; 76(4):185-194. PubMed ID: 39419019 [TBL] [Abstract][Full Text] [Related]
4. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway. Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383 [TBL] [Abstract][Full Text] [Related]
5. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related]
6. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling. Peng J; Liu X; Mao Y; Lv M; Ma T; Liu J; Zhou Q; Han Y; Li X; Wang H Mol Carcinog; 2024 Aug; 63(8):1588-1598. PubMed ID: 38780151 [TBL] [Abstract][Full Text] [Related]
8. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969 [TBL] [Abstract][Full Text] [Related]
9. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R Gene; 2022 Apr; 819():146246. PubMed ID: 35122924 [TBL] [Abstract][Full Text] [Related]
10. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer. Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S Cell Signal; 2024 Aug; 120():111196. PubMed ID: 38697448 [TBL] [Abstract][Full Text] [Related]
11. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609 [TBL] [Abstract][Full Text] [Related]
12. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin. Shen H; Yan W; Yuan J; Wang Z; Wang C J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4. Nan J; Hu X; Guo B; Xu M; Yao Y Bioengineered; 2022 Apr; 13(4):10564-10577. PubMed ID: 35442158 [TBL] [Abstract][Full Text] [Related]
14. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT. Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326 [TBL] [Abstract][Full Text] [Related]
15. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway. Liu G; Wang P; Zhang H J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779 [TBL] [Abstract][Full Text] [Related]
16. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression. Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis. Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y Gene; 2020 Jul; 747():144657. PubMed ID: 32298762 [TBL] [Abstract][Full Text] [Related]
19. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313 [TBL] [Abstract][Full Text] [Related]
20. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation. Shome R; Ghosh SS Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]